Aclaris Therapeutics Inc (ACRS) currently has a stock price of $1.87. The stock saw a sharp increase in the last trading session, hitting a high of $16.0 after opening at $1.87. The lowest recorded price for the day was $2.0 before it closed at $1.69.
Aclaris Therapeutics Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $5.17 on 11/19/24, while the lowest price during the same period was $1.05 on 04/10/25.
52-week price history of ACRS Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Aclaris Therapeutics Inc’s current trading price is -63.83% away from its 52-week high, while its distance from the 52-week low is 78.10%. The stock’s price range during this period has fluctuated between $1.05 and $5.17. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.61 million for the day, which was evidently higher than the average daily volume of 1.13 million over the last three months.
Financial Performance and Market Capitalization
Aclaris Therapeutics Inc (ACRS) has experienced a quarterly rise of 53.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 202.58M and boasts a workforce of 64 employees.
Analysts’ Ratings For Aclaris Therapeutics Inc
As of right now, 4 analysts are rating Aclaris Therapeutics Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4426, with a change in price of +0.1700. Similarly, Aclaris Therapeutics Inc recorded 1,012,677 in trading volume during the last 100 days, posting a change of +10.00%.
ACRS Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ACRS stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
ACRS Stock Stochastic Average
Aclaris Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 95.50%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 94.25%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 70.64% and 58.32%, respectively.
ACRS Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a gain of 57.14%.However, over the last six months, we can see a stronger performance of -15.00%. Over the last 30 days, the price of ACRS has fallen by 17.61%. And in the last five days, it has surged by 14.72%.
